Skip to content

Depression: all studies

Page 663 of 1,036: studies 6,621 to 6,630 of 10,358, newest first. Back to the depression overview

Research

Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.

Journal of Psychopharmacology January 27, 2024 Jessica Barbut Siva, Tommaso Barba, Hannes Kettner et al. 29 citations

Background: There is growing evidence for the therapeutic effects of psychedelics. However, it is still uncertain how these drugs interact with serotonergic antidepressants (serotonin reuptake inhibitors (SRIs)). Objective: This study explores the interaction between psychedelics and SRIs in terms of therapeutic effects. The objective is to compare acute psychedelic effects and subsequent...

DOI: 10.1177/02698811231224217 (opens in new tab) Full text (opens in new tab) Psychedelics Antidepressants Mental health Drug interactions +1

Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial.

BMC Psychiatry January 26, 2024 Laetitia Vanderijst, Felix Hever, Anne Buot et al. 11 citations

A significant number of individuals with alcohol use disorder remain unresponsive to currently available treatments, which calls for the development of new alternatives. In parallel, psilocybin-assisted therapy for alcohol use disorder has recently yielded promising preliminary results. Building on extant findings, the proposed study is set to evaluate the feasibility and preliminary clinical...

DOI: 10.1186/s12888-024-05502-y (opens in new tab) Full text (opens in new tab) Psychedelic therapy Psilocybin-assisted therapy Serotonergic psychedelics Clinical trials +3

EFECTOS PSICOLÓGICOS DE LA PSILOCIBINA EN PACIENTES CON CÁNCER TERMICO: Una revisión del alcance

LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) January 24, 2024

Psilocybin is a natural substance with hallucinogenic properties that has recently been used in the field of health. It is an alkaloid that, when associated with psychotherapy, has shown benefits in the treatment of depression and anxiety. This study aims to analyze the current state of knowledge about the psychological effects of psilocybin in patients with terminal cancer. The method used was...

Psychology, Meditation, and the Brain Across Contemplative Traditions

The Oxford Handbook of Psychology and Spirituality January 23, 2024 Brendan D. Kelly

Abstract Virtually all of the world’s major spiritual and religious traditions incorporate elements of meditation or contemplative prayer, although the nature, prominence, and precise features of such practices vary between traditions. Neuroscientific findings indicate that meditation is associated with significant, enduring alterations in patterns of activity in specific brain areas. These, in...

Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study

Cannabis and Cannabinoid Research January 22, 2024 L. Bidwell, Renée Martin-Willett, Carillon J. Skrzynski et al.

Objective: Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have varying pharmacological actions with differential effects on acute and extended affective states, incuding anxiety. We aimed to study these effects on anxiety in legal market forms of cannabis. Method: This study makes use of a nonequivalent control group quasiexperimental design. Forty-two participants with anxiety symptions...

Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists

Current Psychiatry Research and Reviews January 21, 2024 Payal Ghosh, Debjeet Sur 1 citation

: Psychedelics are currently being examined once more as potential remedies for untreatable biological illnesses after decades of research problems. They are frequently regarded to be physically safe and do not frequently lead to dependency or addiction. The use of psychedelic substances in the treatment of mental illness and the adoption of the Substance Act of 1970 has classified psychedelic...

Psychedelics for mental health: a biochemical perspective

The Biochemist January 19, 2024 Javier González-Maeso

Psychedelics, such as psilocybin, mescaline and lysergic acid diethylamide (LSD), are psychoactive substances that induce alterations in cognition, perception and sensory processing. Studies in rodent models and healthy human volunteers highlight the serotonin 5-HT2A receptor’s pivotal role in mediating hallucinogenic effects. More recent findings indicate that psychedelics induce lasting...

Turnt, Trippy, and Tipsy: Video Games, Drugs, and Allo-Ludic Play

Anglica Wratislaviensia January 18, 2024 Mike Piero 1 citation

This article offers a flexible method for analyzing drug representations in video games as they map onto lived social realities outside the game with a particular focus on US cultures. While drugs have received ample attention in popular culture studies—especially in film and television studies—game studies has been slow to produce systematic analyses of these important cultural artefacts...

Nightmare experiences and perceived ethnic discrimination amongst female university students in the United Arab Emirates: a cross‐sectional study

Journal of Sleep Research January 17, 2024 María Campo-Redondo, Gabriel Andrade

Perceived ethnic discrimination is known to be associated with anxiety and depression, and in turn, anxiety and depression are known to be associated with nightmare frequency and distress. This elicits a question: is perceived ethnic discrimination associated with nightmare frequency and distress? In this study, 179 female university students from the United Arab Emirates were assessed to...

Ketamine Produces Antidepressant Effects by Inhibiting Histone Deacetylases and Upregulating Hippocampal Brain-Derived Neurotrophic Factor Levels in a Diisopropyl Fluorophosphate-Based Rat Model of Gulf War Illness.

Journal of Pharmacology and Experimental Therapeutics January 17, 2024 Ana Ribeiro-Davis, Dalia Y Al Saeedy, Fay M Jahr et al. 10 citations

Approximately one-third of Gulf War veterans suffer from Gulf War Illness (GWI), which encompasses mood disorders and depressive symptoms. Deployment-related exposure to organophosphate compounds has been associated with GWI development. Epigenetic modifications have been reported in GWI veterans. We previously showed that epigenetic histone dysregulations were associated with decreased...

DOI: 10.1124/jpet.123.001824 (opens in new tab) Full text (opens in new tab) Ketamine therapy Neuroscience research Veterans health Depression treatment +1